You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castleman Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ProducingNovel Symptom Burden Scale for People Living With

Not yet recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Research questions
  • (no location specified)
Aug 17, 2023

KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

Not yet recruiting
  • KSHV Inflammatory Cytokine Syndrome (KICS)
  • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 2, 2023

Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)

Recruiting
  • Castleman Disease
  • Castleman's Disease, Multicentric
  • Little Rock, Arkansas
  • +3 more
Jan 6, 2023

Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Completed
  • Castleman Disease
  • +2 more
  • surgery type/exstirpation/debulking
  • (no location specified)
Jun 28, 2022

Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide

Recruiting
  • Castleman Disease
  • +8 more
    • Philadelphia, Pennsylvania
    • +9 more
    Dec 5, 2022

    Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

    Recruiting
    • Multicentric Castleman Disease
    • Lilongwe, Malawi
      UNC Project, Kamuzu Central Hospital
    May 2, 2022

    Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH), Non-Langerhans-Cell Histiocytosis Trial in Cleveland (Genetic

    Recruiting
    • Castleman's Disease (CD)
    • +2 more
    • Genetic testing
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jun 21, 2022

    Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

    Active, not recruiting
    • Lymphoproliferative Disorder
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    s From HIV Infection, KSHV Infection, Viral-Related

    Recruiting
    • HIV
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Collecting Blood and Tissue Sample Donations for Research for

      Not yet recruiting
      • Anal Carcinoma
      • +11 more
      • Biospecimen Collection
      • (no location specified)
      Dec 21, 2022

      Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

      Recruiting
      • Idiopathic Multicentric Castleman's Disease
      • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
      • +2 more
      • Beijing, China
      • +2 more
      Apr 26, 2022

      A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

      Recruiting
      • Multiple Myeloma
      • +11 more
      • No intervention
      • Beijing, China
        Peking University First Hospital
      Apr 21, 2022

      Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

      Terminated
      • Idiopathic Multicentric Castleman's Disease
      • Lansing, Michigan
        Edward W. Sparrow Hospital
      Apr 15, 2021

      Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

      Recruiting
      • Burkitt Lymphoma
      • +2 more
      • Rituximab and Hyaluronidase Human
      • +8 more
      • Kampala, Uganda
        UCI-Fred Hutch Cancer Centre
      Mar 9, 2022

      Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

      Recruiting
      • Multiple Myeloma
      • +8 more
        • Chapel Hill, North Carolina
          North Carolina Cancer Hospital
        Nov 30, 2021

        HHV8 and Solid Organ Transplantation

        Recruiting
        • HHV8
        • +7 more
        • Diagnostic test for HHV8 exposure
        • Milan, Italy
          Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
        Oct 4, 2021

        Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

        Recruiting
        • Idiopathic Multicentric Castleman's Disease
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Feb 5, 2021

        Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia Trial run by the NCI (Zidovudine, Tocilizumab,

        Completed
        Has Results
        • Castleman Disease
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Oct 8, 2020

        Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +38 more
        • Bevacizumab
        • +5 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 18, 2022

        Multicentric Castleman Disease Trial in Beijing (Thalidomide, cyclophosphamide and prednisone)

        Unknown status
        Has Results
        • Multicentric Castleman Disease
        • Thalidomide, cyclophosphamide and prednisone
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Apr 5, 2020

        Idiopathic Multicentric Castleman's Disease Trial in Beijing (Bortezomib, Cyclophosphamide, Dexamethason)

        Recruiting
        • Idiopathic Multicentric Castleman's Disease
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jun 9, 2019

        Castleman Disease Collaborative Network Biobank

        Withdrawn
        • Castleman Disease
        • +8 more
        • Sample Collection
        • Philadelphia, Pennsylvania
          Castleman Disease Collaborative Network
        Jul 28, 2018

        Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

        Not yet recruiting
        • Schwannomatosis
        • +2 more
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        Jan 5, 2023

        Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma Trial (Pomalidomide,

        Withdrawn
        • Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
        • Primary Effusion Lymphoma
        • (no location specified)
        Aug 29, 2018

        Schizophrenia, Psychotic Disorders Trial in Augusta (Siltuximab, normal saline)

        Recruiting
        • Schizophrenia
        • Psychotic Disorders
        • Augusta, Georgia
          Augusta University
        Jul 27, 2021